1. Bernstein AJ, Peters KM. Expanding indications for neuromodulation. Urol Clin North Am. 2005. 32:59–63.
2. Aboseif S, Tamaddon K, Chalfin S, Freedman S, Kaptein J. Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction. Urology. 2002. 60:52–56.
3. European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products. CPMP/EWP/18/01. Note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence. 2002. 12. London:
4. Coyne KS, Matza LS. Validation of the perception of bladder condition measure in overactive bladder. 2002. In : 7th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; Arlington, VA.
5. Schmidt RA. Advances in genitourinary neurostimulation. Neurosurgery. 1986. 19:1041–1044.
6. Tanagho EA, Schmidt RA. Electrical stimulation in the clinical management of the neurogenic bladder. J Urol. 1988. 140:1331–1339.
7. van Voskuilen AC, Oerlemans DJ, Weil EH, de Bie RA, van Kerrebroeck PE. Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol. 2006. 49:366–372.
8. Jonas U, Fowler CJ, Chancellor MB, Elhilali MM, Fall M, Gajewski JB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol. 2001. 165:15–19.
9. Spinelli M, Bertapelle P, Cappellano F, Zanollo A, Carone R, Catanzaro F, et al. Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. J Urol. 2001. 166:541–545.
10. Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003. 169:1369–1373.
11. Kessler TM, Buchser E, Meyer S, Engeler DS, Al-Khodairy AW, Bersch U, et al. Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland. Eur Urol. 2007. 51:1357–1363.
12. Siegel SW, Catanzaro F, Dijkema HE, Elhilali MM, Fowler CJ, Gajewski JB, et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology. 2000. 56(6):Suppl 1. 87–91.
13. Shaker HS, Hassouna M. Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence. J Urol. 1998. 159:1516–1519.
14. Siegel SW. Management of voiding dysfunction with an implantable neuroprosthesis. Urol Clin North Am. 1992. 19:163–170.
15. Janknegt RA, Weil EH, Eerdmans PH. Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology. 1997. 49:358–362.
16. Chai TC, Mamo GJ. Modified techniques of S3 foramen localization and lead implantation in S3 neuromodulation. Urology. 2001. 58:786–790.
17. Spinelli M, Giardiello G, Arduini A, van den Hombergh U. New percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results. Eur Urol. 2003. 43:70–74.
18. Spinelli M, Giardiello G, Gerber M, Arduini A, van den Hombergh U, Malaguti S. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol. 2003. 170:1905–1907.